Fayez Sarofim & Co’s CME Group CME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $342M | Sell |
|
|||||
|
2025
Q1 | $337M | Sell |
|
|||||
|
2024
Q4 | $354M | Buy |
|
|||||
|
2024
Q3 | $324M | Buy |
|
|||||
|
2024
Q2 | $268M | Buy |
|
|||||
|
2024
Q1 | $245M | Buy |
|
|||||
|
2023
Q4 | $227M | Buy |
|
|||||
|
2023
Q3 | $150M | Buy |
|
|||||
|
2023
Q2 | $80.7M | Buy |
|
|||||
|
2023
Q1 | $36.1M | Buy |
|
|||||
|
2022
Q4 | $4.38M | Buy |
|
|||||
|
2022
Q3 | $3.41M | Buy |
|
|||||
|
2022
Q2 | $3.84M | Buy |
|
|||||
|
2022
Q1 | $4.17M | Buy |
|
|||||
|
2021
Q4 | $1.17M | Buy |
|
|||||
|
2021
Q3 | $914K | Buy |
|
|||||
|
2021
Q2 | $991K | Buy |
|
|||||
|
2021
Q1 | $734K | Buy |
|
|||||
|
2020
Q4 | $650K | Buy |
|
|||||
|
2020
Q3 | $581K | Buy |
|
|||||
|
2020
Q2 | $523K | Buy |
|
|||||
|
2020
Q1 | $341K | Buy |
|